Borkowska, A.M.; Szumera-Ciećkiewicz, A.; Szostakowski, B.; Pieńkowski, A.; Rutkowski, P.L.
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. Cancers 2022, 14, 2290.
https://doi.org/10.3390/cancers14092290
AMA Style
Borkowska AM, Szumera-Ciećkiewicz A, Szostakowski B, Pieńkowski A, Rutkowski PL.
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. Cancers. 2022; 14(9):2290.
https://doi.org/10.3390/cancers14092290
Chicago/Turabian Style
Borkowska, Aneta Maria, Anna Szumera-Ciećkiewicz, Bartłomiej Szostakowski, Andrzej Pieńkowski, and Piotr Lukasz Rutkowski.
2022. "Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence" Cancers 14, no. 9: 2290.
https://doi.org/10.3390/cancers14092290
APA Style
Borkowska, A. M., Szumera-Ciećkiewicz, A., Szostakowski, B., Pieńkowski, A., & Rutkowski, P. L.
(2022). Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence. Cancers, 14(9), 2290.
https://doi.org/10.3390/cancers14092290